The National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Research Center (VCR)/ NIAID Vaccine Immune T cell and Antibody Laboratory Core (NVITAL) intends to negotiate on an other than full and open competition basis with LabKey Corporation, 617 Eastlake Ave, East #400, Seattle, WA 98109 for a LabKey software renewal. This acquisition will be processed under FAR Part 12 - Acquisition for Commercial Items and will be made pursuant to the authority in FAR Part 13.501(a)(1).

Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type of contract.

This LabKey software renewal will be utilized to collect and analyze data created by neutralizing antibody (NAb) assays. This is a critical aspect of on-going research and must be renewed to ensure ongoing research projects are not adversely affected. Software renewal can only be provided by LabKey Corporation.

The statutory authority for this sole source requirement is 41 U.S.C. 253 (c) (1) as implemented by FAR 6.302-1 only one source available, no substitutions possible, and equipment must be compatible with existing equipment. THIS IS NOT A SOLICITATION FOR COMPETITIVE QUOTATIONS. All responsible sources who can provide the same or similar equipment may submit a response that could be considered by email to Brad Engel at [email protected] by the specified date/time of this notice. All information furnished must be in writing and must contain sufficient detail to allow NIAID to determine if it can meet the above unique specifications described herein. All responses received by the closing date of this solicitation will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.

Bid Protests Not Available